Abstract
An open, comparative multicenter study was performed to evaluate the efficacy and safety of azithromycin (10 mg/kg) given once daily for three days in comparison with cefaclor (30 mg/kg) divided into three daily doses and given for a period of ten days. One hundred and twenty-two children aged 1–12 years with clinical symptoms of group Aβ-hemolytic Streptococcal tonsillopharyngitis and a positive throat culture were randomly allocated to the treatment groups. Overall, the clinical success (cure or improvement) of both regimens was identical in the evaluable patients (86.3%, 44 of 51 patients in either treatment group). In contrast, bacterial eradication after completion of treatment was lower with azithromycin than with cefaclor. Possible reasons for this discrepancy between clinical success and eradication rates could be antibiotic resistance, pre-disease carriage or insufficient dosage. Both agents were well tolerated; only mild or moderate side effects most frequently involving the gastrointestinal tract, were recorded in either therapy group.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Gastanaduy AS, Kaplan EL, Huwe BB, McKay C, Wannamaker LW: Failure of penicillin to eradicate group A streptococci during an outbreak of pharyngitis. Lancet (1980) ii:498–501
Still GJ: Management of pediatric patients with group A beta-hemolyticStreptococcus pharyngitis: treatment options. Pediatric Infectious Disease Journal (1995) 14, Supplement:57–61
Brook I: Role of beta-lactamase producing bacteria in the failure of penicillin to eradicate group A streptococci. Pediatric Infectious Disease Journal (1985) 4:491–495
Pichichero ME: Explanations and therapies for penicillin failure in streptococcal pharyngitis. Clinical Pediatrics (1992) 31:642–649
Pichichero ME, Disney FA, Talpey WB, Green JL, Francis AB, Roghmann KJ, Hoeckelmann RA: Adverse and beneficial effects of immediate treatment of group A beta-hemolytic streptococcal pharyngitis with penicillin. Pediatric Infectious Disease Journal (1987) 6:635–643
Stillermann M: Comparison of oral cephalosporins with penicillin therapy for group A streptococcal pharyngitis. Pediatric Infectious Disease Journal (1986) 5:649–654
Pichichero ME, Margolis PA: A comparison of cephalosporins and penicillins in the treatment of group A beta-hemolytic streptococcal pharyngitis: a meta-analysis supporting the concept of microbial co-pathogenecity. Pediatric Infectious Disease Journal (1991) 10:275–281
Pichichero ME: The rising incidence of penicillin treatment failure in group A streptococcal tonsillopharyngitis: an emerging role for the cephalosporins. Pediatric Infectious Disease Journal (1991) 10, Supplement:50–55
Maskell JP, Sefton AM, Williams JD: Comparative in-vitro activity of azithromycin and erythromycin against gram-positive cocci,Haemophilus influenzae and anaerobes. Journal of Antimicrobial Chemotherapy (1990) 25, Supplement A:19–24
Giovanetti E, Prenna M, Repetto A, Biavasco F, Romagnoli M, Ripa S, Varaldo PE: Suseptibility ofStreptococcus pyogenes from throat cultures to macrolide antibiotics and influence of collection criteria. Clinical Microbiology and Infection (1997) 3:58–62
Nahata MC: Pharmacokinetics of azithromycin in pediatric patients: comparison with other agents used for treating otitis media and streptococcal pharyngitis. Pediatric Infectious Disease Journal (1995) 14, Supplement:39–44
Hooton TM: A comparison of azithromycin and penicillin V for the treatment of streptococcal pharyngitis. American Journal of Medicine (1991) 91, Supplement 3A:23–26
Hamill J: Multicentre evaluation of azithromycin and penicillin V in the treatment of acute streptococcal pharyngitis and tonsillitis in children. Journal of Antimicrobial Chemotherapy (1993) 31, Supplement E:89–94
Weippl G: Multicentre comparison of azithromycin versus erythromycin in the treatment of pediatric pharyngitis or tonsillitis caused by group A streptococci. Journal of Antimicrobial Chemotherapy (1993) 31, Supplement E:95–101
Schaad UB, Heynen G: Evaluation of the efficacy, safety and toleration of azithromycin vs. penicillin V in the treatment of acute streptococcal pharyngitis in children: results of a multicenter, open comparative study. Pediatric Infectious Disease Journal (1996) 15:791–795
Pacifico L, Scopetti F, Ranucci A, Pataracchia M, Savignoni F, Chiesa C: Comparative efficacy and safety of 3-day azithromycin and 10 day penicillin V treatment of group A beta-hemolytic streptococcal pharyngitis in children. Antimicrobial Agents and Chemotherapy (1996) 40:1005–1008
Braveny I: Fortschritte beim Nachweis beta-hämolytischer Streptokokken. Deutsche Medizinische Wochenschrift (1971) 96:396–397
Still JG: Azithromycin vs. penicillin suspension in treatment of children with streptococcal pharyngitis. Clinical Pharmacology and Therapeutics (1993) 53:195
Henness DM: A clinical experience with cefadroxil in upper respiratory tract infection. Journal of Antimicrobial Chemotherapy (1982) 10, Supplement B:125–135
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cremer, J., Wallrauch, C., Milatovic, D. et al. Azithromycin versus cefaclor in the treatment of pediatric patients with acute group a beta-hemolytic streptococcal tonsillopharyngitis. Eur. J. Clin. Microbiol. Infect. Dis. 17, 235–239 (1998). https://doi.org/10.1007/BF01699979
Issue Date:
DOI: https://doi.org/10.1007/BF01699979